title: Economic impact of oral ciprofloxacin following standard intravenous therapy.
authors.affiliation: Section of Infectious Disease, Christ Hospital and Medical Center, Oak Lawn, Illinois 60453.
authors.forename: R M
authors.initials: RM
authors.lastname: Fliegelman
authors.forename: P M
authors.initials: PM
authors.lastname: Mattingly
authors.forename: C L
authors.initials: CL
authors.lastname: Dempsey
authors.forename: S J
authors.initials: SJ
authors.lastname: Sokalski
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007902:Length of Stay / Q000191:economics; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D012141:Respiratory Tract Infections / Q000188:drug therapy*
chemical_list: D002939:Ciprofloxacin